Dozens of commonly prescribed medications can raise bilirubin levels, and they do so through several different mechanisms. Some damage liver cells directly, others block the liver’s ability to process bilirubin, and a few destroy red blood cells faster than the liver can keep up. Normal total bilirubin falls between 0.2 and 1.3 mg/dL in adults, and drug-induced elevations can push levels well above that range.
Understanding which category your medication falls into matters, because it determines whether the elevation is a harmless lab quirk or a sign of real liver trouble.
How Medications Raise Bilirubin
Bilirubin is a waste product created when your body breaks down old red blood cells. Normally, it travels through the blood to the liver, where it gets chemically modified (conjugated) so it can dissolve in bile and leave your body through stool. A drug can disrupt this process at any step along the way, and the step it disrupts determines what type of bilirubin rises on your blood test.
When a drug destroys red blood cells or blocks the liver from pulling bilirubin out of the blood, unconjugated (indirect) bilirubin rises. When a drug damages liver cells or blocks bile flow, conjugated (direct) bilirubin rises instead. Some medications affect multiple steps at once.
Drugs That Destroy Red Blood Cells
Certain medications trigger the destruction of red blood cells, a process called hemolysis. When red blood cells break down faster than normal, the liver gets flooded with bilirubin it can’t process quickly enough, and unconjugated levels climb. This is especially common in people with a genetic condition called G6PD deficiency, which affects roughly 400 million people worldwide.
The main culprits include sulfa drugs (like sulfamethoxazole, often prescribed for urinary tract infections) and nitrofurantoin (another common UTI antibiotic). In people with G6PD deficiency, these drugs can cause a rapid spike in bilirubin that leads to visible yellowing of the skin and eyes within days of starting the medication.
Drugs That Block Liver Uptake or Processing
Some medications interfere with the liver’s ability to grab bilirubin from the bloodstream or convert it into its water-soluble form. Rifampin, an antibiotic used for tuberculosis, competes directly with bilirubin for entry into liver cells. It also interferes with the liver’s excretory pathways, which means bilirubin backs up even when the liver is otherwise healthy. This is why rifampin is actually used as a diagnostic tool: doctors sometimes give a single dose to see how much bilirubin rises, which helps diagnose Gilbert’s syndrome.
Probenecid, a gout medication, works differently. It blocks the transport of a key molecule that liver cells need to conjugate bilirubin, effectively slowing down the processing step. Chloramphenicol, an older antibiotic, also reduces liver uptake of bilirubin. Ethinyl estradiol, the estrogen found in many birth control pills, can decrease the liver’s conjugation capacity as well.
Drugs That Damage Liver Cells Directly
This is the category that raises the most concern. When a medication injures or kills liver cells, those cells release their contents into the blood and lose the ability to process bilirubin. The result is a rise in both bilirubin and liver enzymes.
Acetaminophen (Tylenol) is the most well-known example, particularly in overdose. Liver damage from acetaminophen follows a predictable timeline: liver enzymes and bilirubin begin rising 24 to 72 hours after ingestion, peak between 72 and 96 hours, and either resolve or progress to organ failure after about five days. At therapeutic doses, acetaminophen rarely causes problems, but high doses or chronic use, especially combined with alcohol, can push bilirubin into dangerous territory.
Other medications in this category include isoniazid (a tuberculosis drug), amiodarone (a heart rhythm medication), statins (cholesterol-lowering drugs), and NSAIDs like ibuprofen and diclofenac. Statins generally have a low potential for severe liver injury, but they can produce mild, transient elevations in bilirubin and liver enzymes that show up on routine blood work.
Antibiotics That Cause Bile Backup
A number of antibiotics cause cholestasis, a condition where bile flow from the liver slows or stops. Since conjugated bilirubin normally exits the body through bile, any blockage sends it back into the bloodstream. Symptoms include jaundice, itching, pale stools, dark urine, nausea, and abdominal pain.
Amoxicillin-clavulanate (Augmentin) is one of the most commonly reported antibiotics behind drug-induced liver injury. It can cause cholestatic, hepatocellular, or mixed patterns of damage, sometimes appearing weeks after the course of antibiotics has ended. Erythromycin, flucloxacillin, doxycycline, and cotrimoxazole all tend to produce a cholestatic pattern. Ciprofloxacin can cause both cholestatic and hepatocellular injury.
These reactions are unpredictable and not dose-dependent. They represent an idiosyncratic response, meaning they happen in a small number of people for reasons that aren’t fully understood.
Hormones and Anabolic Steroids
Oral contraceptives containing estrogen can cause intrahepatic cholestasis, particularly in women who are genetically predisposed. The estrogen component interferes with bile secretion at the cellular level, leading to a buildup of conjugated bilirubin. This is the same mechanism behind cholestasis of pregnancy, which occurs in women who are sensitive to the high estrogen levels of late pregnancy.
Anabolic steroids, whether prescribed or used for performance enhancement, are well-established causes of cholestatic liver injury. They can produce significant jaundice that takes weeks to resolve after the drug is stopped.
Cancer Drugs and HIV Medications
Certain cancer and HIV drugs raise bilirubin by directly inhibiting the enzyme (UGT1A1) that conjugates bilirubin in the liver. This is the same enzyme that’s underactive in people with Gilbert’s syndrome, so the effect mimics that genetic condition.
Irinotecan, a chemotherapy drug, is a well-known inhibitor of this enzyme. People with genetic variants that already reduce UGT1A1 activity can experience severe bilirubin spikes on irinotecan, which is why genetic testing is sometimes done before starting treatment. Sorafenib, another cancer drug, also inhibits UGT1A1 and can cause clinically significant elevations.
Among HIV medications, the protease inhibitor atazanavir is the most notable. It inhibits bilirubin conjugation so reliably that mild jaundice is considered a known side effect rather than a sign of liver damage. The bilirubin elevation is almost entirely unconjugated, and it resolves when the drug is stopped.
Gilbert’s Syndrome Makes It Worse
About 5 to 10 percent of the population has Gilbert’s syndrome, a harmless genetic condition where the bilirubin-processing enzyme runs at roughly 30 percent of normal capacity. Most people with Gilbert’s syndrome never know they have it unless a blood test catches mildly elevated bilirubin during fasting or illness.
The problem arises when these individuals take medications that further suppress the same enzyme. Drugs like irinotecan, atazanavir, and other protease inhibitors can cause bilirubin to spike much higher in people with Gilbert’s syndrome than in the general population. The enzyme is already slow, and adding a chemical inhibitor on top can overwhelm the system. This doesn’t always mean the drug must be avoided, but it often means closer monitoring or dose adjustments.
When Elevated Bilirubin Signals Danger
A mild, isolated rise in bilirubin with normal liver enzymes is often benign, especially if you’re taking a drug known to affect bilirubin processing without causing liver damage (like atazanavir or rifampin). The clinical picture changes when bilirubin rises alongside liver enzymes.
The FDA uses a benchmark called Hy’s Law to flag serious drug-induced liver injury during clinical trials. The pattern that raises alarm is a significant rise in liver enzymes combined with a total bilirubin above twice the upper limit of normal (roughly above 2.6 mg/dL), without bile duct obstruction explaining it. This combination carries a fatality rate of around 10 percent if the offending drug isn’t stopped.
Visible jaundice, the yellowing of skin and eyes, typically appears when total bilirubin exceeds about 2.5 to 3 mg/dL. If you notice yellowing while taking any medication, that warrants prompt medical evaluation. Other warning signs include dark brown urine, clay-colored stools, severe fatigue, nausea, and right-sided abdominal pain. These symptoms suggest the liver or bile flow is significantly affected and the medication likely needs to be stopped or changed.